{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:57:06Z","timestamp":1761919026359},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s10072-007-0823-z","type":"journal-article","created":{"date-parts":[[2007,8,9]],"date-time":"2007-08-09T12:42:37Z","timestamp":1186663357000},"page":"209-211","source":"Crossref","is-referenced-by-count":48,"title":["Variable responses to rituximab treatment in neuromyelitis optica (Devic\u2019s disease)"],"prefix":"10.1007","volume":"28","author":[{"given":"M.","family":"Capobianco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Malucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"di Sapio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bottero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Marnetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Doriguzzi Bozzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bertolotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,10]]},"reference":[{"key":"823_CR1","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"D.M. Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O\u2019Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology 53:1107\u20131114","journal-title":"Neurology"},{"key":"823_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00415-004-0271-0","volume":"251","author":"A. Ghezzi","year":"2004","unstructured":"Ghezzi A, Bergamaschi R, Martinelli V et al and the Italian Devic\u2019s Study Group (IDESG) (2004) Clinical characteristics, course and prognosis of relapsing Devic\u2019s Neuromyelitis Optica. J Neurol 251:47\u201352","journal-title":"J Neurol"},{"key":"823_CR3","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"C.F. Lucchinetti","year":"2002","unstructured":"Lucchinetti CF, Mandler RN, McGavern D et al (2002) A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain 125:1450\u20131461","journal-title":"Brain"},{"key":"823_CR4","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"V.A. Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106\u20132112","journal-title":"Lancet"},{"key":"823_CR5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1084\/jem.20050304","volume":"202","author":"V.A. Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ et al (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:474\u2013477","journal-title":"J Exp Med"},{"key":"823_CR6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11940-005-0010-6","volume":"7","author":"D.M. Wingerchuk","year":"2005","unstructured":"Wingerchuk DM, Weinshenker BG (2005) Neuromyelitis optica. Curr Treat Options Neurol 7:173\u2013182","journal-title":"Curr Treat Options Neurol"},{"key":"823_CR7","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","volume":"64","author":"B.A.C. Cree","year":"2005","unstructured":"Cree BAC, Lamb S, Morgan K et al (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64:1270\u20131272","journal-title":"Neurology"},{"key":"823_CR8","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"D.M. Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittok SJ et al (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485\u20131489","journal-title":"Neurology"},{"key":"823_CR9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1212\/01.wnl.0000223346.09426.34","volume":"67","author":"P.H. Lalive","year":"2006","unstructured":"Lalive PH, Menge T, Barman I et al (2006) Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays. Neurology 67:176\u2013177","journal-title":"Neurology"},{"key":"823_CR10","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archneur.63.7.957","volume":"63","author":"B. Weinstock-Guttman","year":"2006","unstructured":"Weinstock-Guttman B, Ramanathan M, Lincoff N et al (2006) Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease). Arch Neurol 63:957\u2013963","journal-title":"Arch Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-007-0823-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-007-0823-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-007-0823-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:11:33Z","timestamp":1559121093000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-007-0823-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["823"],"URL":"https:\/\/doi.org\/10.1007\/s10072-007-0823-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}